FACTS FIGURES FEATURES

(1)

Progetti finanziati nell’ambito del Programma per la Cooperazione Transfrontaliera Italia-Slovenia 2007-2013, dal Fondo europeo di sviluppo regionale e dai fondi nazionali.

Projekti sofinancirani v okviru Programa čezmejnega sodelovanja Slovenija-Italija 2007-2013 iz sredstev Evropskega sklada za regionalni razvoj in nacionalnih sredstev.

1

FACTS

FIGURES

FEATURES

Sabina Passamon+

University of Trieste

Lead Partner of Trans2Care

(2)

WHY THIS CONFERENCE?

•

Six projects with 44 diﬀerent partners have received 8.48

MLN € from the Cross-‐Border Coopera+on Programme Italy-‐

Slovenia 2007-‐2013.

•

For the ﬁrst +me, researchers have met to share their results

and future perspec+ves:

–

What are the results of this investment?

(3)

FACTS

1.

Wish to share

what we do in our cross-‐

border projects

–

objec+ves, results, vision

2.

Immediate agreement

to meet at this

Conference

3.

An

open event

–

other colleagues have been invited to the

(4)

FIGURES of a\rac+on

è

n of registra+ons

The growing curve of registra+ons:

(5)

The geographical origin of the par+cipants

(6)

FIGURES of a\rac+on

è

traﬃc on the web

(7)

FIGURES of a\rac+on

è

65 posters

evaluated for their

Technolgy Readiness Levels

(8)

UniversiIes

48%

Research

Centers

19%

Hospitals

5%

SMEs

9%

Other

19%

Where do the 181 parIcipants

work ?

(9)

Where do researchers come from?

0"

2"

4"

6"

8"

10"

12"

14"

ELETTRA"

LNCIB"

AREA"

NIB"

INFN"

KI"

ZTM"

CBM"

Research(centers(

N"

0"

5"

10"

15"

20"

25"

30"

35"

40"

Trieste"

Primorska"

Udine"

SISSA"

Nova"Gorica"

Rijeka"

Ferrara"

Venezia"

Verona"

Universi(es)

N"

(10)

That’s the new

FEATURE

of this

Conference !

The new language of TRL

•

Understood by industries

•

Understood by H2020 evaluators

(11)

Progetti finanziati nell’ambito del Programma per la Cooperazione Transfrontaliera Italia-Slovenia 2007-2013, dal Fondo europeo di sviluppo regionale e dai fondi nazionali. Projekti sofinancirani v okviru Programa čezmejnega sodelovanja Slovenija-Italija 2007-2013 iz sredstev Evropskega sklada za regionalni razvoj in nacionalnih sredstev.

T.R.L. ASSESSMENT

FINAL REPORT

Dott. Adriano SAVOINI -

T&B e associa+ Srl

Trans2Care Project Manager

TRL Evaluation Team Coordinator

Team members:

(12)

T.R.L. ASSESSMENT RESULTS

5

10

15

20

25

N.posters

(13)

Progetti finanziati nell’ambito del Programma per la Cooperazione Transfrontaliera Italia-Slovenia 2007-2013, dal Fondo europeo di sviluppo regionale e dai fondi nazionali. Projekti sofinancirani v okviru Programa čezmejnega sodelovanja Slovenija-Italija 2007-2013 iz sredstev Evropskega sklada za regionalni razvoj in nacionalnih sredstev.

CONCLUSIONS / COMMENTS

•

Most technologies need (much)

further development to be ready for

market (average TRL is 3)

•

(Apparently) few links with Industry

•

4-5 techs seem very promising for

market deployment

•

N/A = Not applicable; clinical studies,

(14)

Can this analysis be independently

conﬁrmed?

•

Let’s browse the “Bibliometric analysis of ongoing

projects-‐Innova+ve Medicines Ini+a+ve Joint

Undertaking – Report 2013”

(15)

?

GO TO PAGE 57

OF THE IMI

(16)

Pioneers needed !

It appears that Italy-‐Slovenia Cross-‐border

biomedical researchers are not involved in

collabora+ve research projects and networks of

industrial and academic experts supported by

Innova+ve Medicine Ini+a+ve

(17)

Can the Cross-‐border biomedical

research community provide the

pioneers ?

for smart biomedical industrialisa1on

Let’s analyse the results of our pre-‐conference survey

62 respondents out of ca. 160 registraIons

(18)

The occupa+onal proﬁle of par+cipants

Permanent(

30%(

Temporary(

70%(

What(kind(of(job(contract(do(

you(have(?(

YES$

35%$

NO$

65%$

Does%the%CBC%Programme%Italy2

Slovenia%200722013%fund%your%

contract?%

(19)

i) Clear ideas (turquoise bars)

ii) To be a researcher (blue bars) or an employee (red bars);

ii) Not to be an employer (green bars)

Research(

Enterprise,(as(employee(

Enterprise,(as(employer(

Other(

No(idea(

0,0(

10,0(

20,0(

30,0(

40,0(

50,0(

60,0(

70,0(

unlikely( poorly(

likely(

fairly(

likely(

most(

likely(

9,5$

22,2$

50,8$

30,8$

21,2$

26,9$

19,2$

1,9$

57,1$

4,1$

20,4(

26,5(

6,1(

66,7(

7,1(

%$

What$do$you$plan$for$your$next$job$?$

Research(

Enterprise,(as(employee(

Enterprise,(as(employer(

Other(

No(idea(

(20)

i) First choiche: to work at home (red)

ii) Second choice: to work close to home (blue)

iii) Third choice: to work abroad

20,0#

30,0#

40,0#

20,7#

29,3#

37,9#

38,9#

18,5#

20,4#

14,8#

%#

Where#do#you#plan#to#work#in#the#near#future#?#

In#the#Italy*Slovenia#Programme#Area#

In#your#country#

Abroad#

(21)

WHAT NEEDS TO BE IMPROVED

•

More connecIons

involving reasearchers, industries

and public bodies

•

Intense training

of researchers in the methods and

techniques fostering innova+on

–

eﬀort to develop new skills

–

eﬀort to work across disciplines

–

eﬀort to interact with non-‐researchers

•

A

stronger dialogue

with the policy-‐makers and the

Managing Authority (not just ﬁnancial reports and

online consulta+ons!)

(22)

CONCLUSIONS

•

The aim of this Conference was to assess the

capacity of biomedical researchers to develop

innova+ons.

–

Note: analysis focussed on "Readiness", not on

"quality" of results, methods or approaches

•

There is a large poten+al to progress from the

(23)

NEXT ACTIONS

1.

Conference proceedings book publica+on

2.

Brainstorming session of the coordinators of

the 6 projects

–

to be scheduled

3.

Organisa+on of a brockerage event (June

2014) involving

–

researchers

–

industries

(24)

THANKS

to everybody for your par+cipa+on

to Paola Storici – coorganiser

(25)

THANKS

to Divulgando s.r.l

for crea+ve organisa+onal op+misa+on

website annoncement and management, conference material,

pictures, logis+cs, post-‐event follow-‐up

h\p://www.units.it/vedinews/index.php?id=4209&+ponews=5

h\p://www.ﬂickr.com/photos/trans2care/sets/72157641645322424/

FACTS FIGURES FEATURES

FACTS

and future perspec+ves:

FACTS

The geographical origin of the par+cipants

FIGURES of a\rac+on

Where do researchers come from?

Understood by H2020 evaluators

T&B e associa+ Srl

CONCLUSIONS / COMMENTS

projects-­‐Innova+ve Medicines Ini+a+ve Joint

GO TO PAGE 57

Can the Cross-­‐border biomedical

you(have(?(

i) Clear ideas (turquoise bars)

No(idea(

WHAT NEEDS TO BE IMPROVED

with the policy-­‐makers and the

There is a large poten+al to progress from the

Conference proceedings book publica+on

THANKS

projects-‐Innova+ve Medicines Ini+a+ve Joint

Can the Cross-‐border biomedical

with the policy-‐makers and the